Sackler Scion’s Email Reveals Push for High-Dose OxyContin, New Lawsuit Disclosures Claim
The New York Times -

Purdue Pharma tried to maximize profits by marketing the drug to keep patients on higher doses for longer periods, a lawsuit charges.

Read this story at

Loading...

Related Articles